Journal
/
/
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
DOI:

13:38 min

January 18, 2017

, , , ,

Chapters

  • 00:05Title
  • 01:13Synthesis of Aspirin-fumarate Prodrug, GTCpFE
  • 06:10Inhibiting the NFκB Activity with GTCpFE in Breast Cancer Cells
  • 07:22Inhibiting Breast Cancer Stem Cells with GTCpFE In Vitro
  • 10:11Results: GTCpFE Inhibits the NFκB Pathway, Mammosphere Formation, and the CD44+CD24 Immunophenotype in Breast Cancer Cells
  • 11:49Conclusion

Summary

Automatic Translation

This procedure will demonstrate how we synthesized and characterized the anti-NFκB and anti-cancer stem cell activity of an aspirin-fumarate prodrug.

Related Videos

Read Article